PT75304B - Process for the preparation of novel-lactam antibacterial agents - Google Patents

Process for the preparation of novel-lactam antibacterial agents

Info

Publication number
PT75304B
PT75304B PT75304A PT7530482A PT75304B PT 75304 B PT75304 B PT 75304B PT 75304 A PT75304 A PT 75304A PT 7530482 A PT7530482 A PT 7530482A PT 75304 B PT75304 B PT 75304B
Authority
PT
Portugal
Prior art keywords
novel
preparation
antibacterial agents
lactam antibacterial
lactam
Prior art date
Application number
PT75304A
Other languages
English (en)
Other versions
PT75304A (en
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of PT75304A publication Critical patent/PT75304A/pt
Publication of PT75304B publication Critical patent/PT75304B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/12Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 3 and unsubstituted in position 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D463/00Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16Nitrogen atoms
    • C07D463/18Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D505/00Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
PT75304A 1981-07-25 1982-07-23 Process for the preparation of novel-lactam antibacterial agents PT75304B (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB8123033 1981-07-25
GB8123034 1981-07-25
GB8136824 1981-12-07
GB8136823 1981-12-07
GB8207966 1982-03-18
GB8209954 1982-04-03
GB8209953 1982-04-03
GB8215007 1982-05-22

Publications (2)

Publication Number Publication Date
PT75304A PT75304A (en) 1982-08-01
PT75304B true PT75304B (en) 1984-07-31

Family

ID=27571208

Family Applications (1)

Application Number Title Priority Date Filing Date
PT75304A PT75304B (en) 1981-07-25 1982-07-23 Process for the preparation of novel-lactam antibacterial agents

Country Status (18)

Country Link
US (3) US4539149A (pt)
EP (1) EP0071395B1 (pt)
KR (1) KR900000934B1 (pt)
AU (1) AU568062B2 (pt)
CA (1) CA1216576A (pt)
DE (1) DE3278878D1 (pt)
FI (1) FI78702C (pt)
GB (1) GB2107307B (pt)
GR (1) GR76544B (pt)
HK (1) HK58088A (pt)
KE (1) KE3810A (pt)
MY (1) MY8700744A (pt)
NO (1) NO162192C (pt)
NZ (1) NZ201369A (pt)
PH (4) PH20467A (pt)
PL (2) PL146182B1 (pt)
PT (1) PT75304B (pt)
YU (2) YU43083B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0115405B1 (en) * 1983-01-21 1987-06-10 Beecham Group Plc Process for the preparation of beta-lactam compounds
GB8301694D0 (en) * 1983-01-21 1983-02-23 Beecham Group Plc Beta-lactam antibacterial agents
EP0114752B1 (en) * 1983-01-21 1988-04-06 Beecham Group Plc Beta-lactam antibacterial agents
DE3468027D1 (en) * 1983-01-21 1988-01-21 Beecham Group Plc Beta-lactam antibacterial agents
NZ206893A (en) * 1983-01-24 1987-02-20 Beecham Group Plc Cephalosporin derivatives and pharmaceutical compositions;and 7-amino intermediates
EP0131174B1 (en) * 1983-07-07 1989-09-13 Beecham Group Plc Substituted phenylglycine derivatives of beta-lactam antibiotics
JPS6066987A (ja) * 1983-09-20 1985-04-17 Takeda Chem Ind Ltd 抗生物質taν−547,その製造法および微生物
EP0150378B1 (en) * 1984-01-23 1990-03-28 Takeda Chemical Industries, Ltd. Cephem compounds and their production
EP0160745A3 (en) * 1984-05-07 1986-11-05 Takeda Chemical Industries, Ltd. Cephem compounds and their production
EP0167011A3 (en) * 1984-06-12 1986-03-19 Beecham Group Plc Beta-lactam compounds, intermediates thereof, their use in preparing beta-lactams having a diketopiperazine group
EP0168177A3 (en) * 1984-06-28 1987-04-01 Pfizer Limited Cephalosporin antibiotics
EP0219926A3 (en) * 1985-06-25 1988-08-31 Beecham Group Plc Cephalosporins, processes for their preparation and pharmaceutical compositions containing them
JPS6230789A (ja) * 1985-08-01 1987-02-09 Yamanouchi Pharmaceut Co Ltd 7−ホルミルアミノセフアロスポリン化合物およびその製造法
EP0211656A3 (en) * 1985-08-10 1988-03-09 Beecham Group Plc Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
GB8531202D0 (en) * 1985-12-18 1986-01-29 Pfizer Ltd Cephalosporin antibiotics
US4666835A (en) * 1986-04-29 1987-05-19 Baldwin Jack E 2-vinylpenams and process
GB8709666D0 (en) * 1987-04-23 1987-05-28 Beecham Group Plc Compounds
GB8719875D0 (en) * 1987-08-22 1987-09-30 Beecham Group Plc Compounds
GB8722477D0 (en) * 1987-09-24 1987-10-28 Beecham Group Plc Compounds
DE3733626A1 (de) * 1987-10-05 1989-04-13 Bayer Ag Heteroanellierte phenylglycin-(beta)-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69016719T2 (de) * 1989-09-04 1995-06-01 Beecham Group Plc Cephalosporinderivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate und Zwischenverbindungen.
US7601864B1 (en) * 2008-05-08 2009-10-13 Ufc Corporation Method for synthesizing 4,4-dihalogen-2-(dialkylamino)methylene-3-oxy-alkylbutyrate and derivatives thereof
WO2013057196A1 (en) 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the preparation of cefamandole nafate
WO2013057197A1 (en) 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the formylation of cefamandole

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR205683A1 (es) * 1970-06-16 1976-05-31 Merck & Co Inc Procedimiento para la preparacion del ester de bencilo del acido 6-metoxi-6-acilamido penicilanico
GB1442302A (en) * 1972-07-21 1976-07-14 Glaxo Lab Ltd Penicillin and cephalosporin derivatives
US3868365A (en) * 1972-12-06 1975-02-25 Squibb & Sons Inc Method for preparing 6-substituted penicillins by replacement of oxygen containing groups
US4062842A (en) * 1973-09-06 1977-12-13 E. R. Squibb & Sons, Inc. Method for preparing 7-substituted cephalosporins and 6-substituted penicillins by replacement of sulfur-containing groups
US3937655A (en) * 1974-04-16 1976-02-10 Eli Lilly And Company Method for preparing stable β-lactam-type-antibiotic susceptibility test discs
US3962214A (en) * 1974-07-11 1976-06-08 Eli Lilly And Company Process for preparing amino substituted β-lactam antibiotics
US4281117A (en) * 1980-09-04 1981-07-28 Eli Lilly And Company Process for 3-chloro cephalosporin nucleus

Also Published As

Publication number Publication date
AU8635182A (en) 1984-10-18
KE3810A (en) 1988-08-05
US4877783A (en) 1989-10-31
YU45671B (sh) 1992-07-20
EP0071395A1 (en) 1983-02-09
PL248815A1 (en) 1985-04-09
NO162192C (no) 1989-11-22
GR76544B (pt) 1984-08-10
PH21703A (en) 1988-01-27
FI78702C (fi) 1989-09-11
HK58088A (en) 1988-08-05
PL237640A1 (en) 1985-01-02
AU568062B2 (en) 1987-12-17
KR900000934B1 (ko) 1990-02-19
US4539149A (en) 1985-09-03
FI822606L (fi) 1983-01-26
FI78702B (fi) 1989-05-31
NO162192B (no) 1989-08-14
KR840000559A (ko) 1984-02-25
PL146182B1 (en) 1989-01-31
YU178484A (en) 1987-12-31
PH21701A (en) 1988-01-27
PT75304A (en) 1982-08-01
FI822606A0 (fi) 1982-07-23
YU43083B (en) 1989-02-28
CA1216576A (en) 1987-01-13
NO822538L (no) 1983-01-26
PL145252B1 (en) 1988-08-31
MY8700744A (en) 1987-12-31
DE3278878D1 (en) 1988-09-15
NZ201369A (en) 1985-12-13
PH20467A (en) 1987-01-14
US4609652A (en) 1986-09-02
EP0071395B1 (en) 1988-08-10
YU162382A (en) 1985-04-30
PH21702A (en) 1988-01-27
GB2107307A (en) 1983-04-27
GB2107307B (en) 1986-02-26

Similar Documents

Publication Publication Date Title
DE3260183D1 (en) Process for the preparation of alpha-alkyl acroleines
PT75304B (en) Process for the preparation of novel-lactam antibacterial agents
PT74526A (en) Process for the preparation of new n-acyl-polypeptides
HRP930089B1 (en) PROCESS FOR THE PREPARATION OF SPS-aze
DE3278474D1 (en) Process for the preparation of di-galactose derivatives
DE3264923D1 (en) Novel process for the preparation of n6-alkyl-arprinocid
EG15838A (en) Process for the preparation of usea
EP0155710A3 (en) Process for the preparation of derivatives of polyethoxypropanesulfonates
DE3261387D1 (en) Process for the preparation of 3-alkyl-3-acyloxy-4-hydroxybutenes
PT74254A (en) Process for the preparation of pyridinyl-substituted-benzimidazole derivatives
PT74339A (en) Process for the preparation of alpha-haloalkylamides
DE3265814D1 (en) Process for the preparation of halogeno-2-mercaptobenzoxazoles
GB2111471B (en) Process for the preparation of acicular -feooh
DE3267346D1 (en) Process for the preparation of urethanes
DE3263745D1 (en) Process for the preparation of 4-aminobutyramide
DE3260205D1 (en) Process for the preparation of 2-chloro-4-nitrotoluene
DE3271847D1 (en) Process for the preparation of hydantoins
ZA825789B (en) Process for the preparation of urea
IL66464A0 (en) Process for the preparation of phenmedipham
DE3263730D1 (en) Process for the preparation of dihydroxypropyltheophylline
IL65983A0 (en) Process for the preparation of beta-cyclo-substituted ethylamines
DE3265390D1 (en) Process for the preparation of 4-thio-azetidinone compounds
IL66819A0 (en) Process for the preparation of macrophages-activating-factor
DE3260445D1 (en) Process for the preparation of 17-alpha-ethynyl-17-beta-trifluoroacetoxy-gon-4-en-3-one derivatives
GB2101997B (en) Process for the preparation of gem-dihalogen compounds

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19930131